Cargando...

IMMU-20. SELECTING AN EPHA2-CAR FOR THE IMMUNOTHERAPY OF DIPG AND GBM

The intent of this project is to develop T cells expressing an EphA2-specific chimeric antigen receptor (CAR) as an immunotherapy for diffuse intrinsic pontine glioma (DIPG) and glioblastoma (GBM). EphA2 is an attractive target given its high expression in GBM but not normal brain tissue. We previou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Prinzing, Brooke, Yi, Zhongzhen, Chow, Kevin, Gottschalk, Stephen, Krenciute, Giedre
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475122/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!